Ausgabe 4/2024
Inhalt (10 Artikel)
Harnessing the Potential of Real-World Evidence in the Treatment of Colorectal Cancer: Where Do We Stand?
Sietske C. M. W. van Nassau, Guus M. Bol, Frederieke H. van der Baan, Jeanine M. L. Roodhart, Geraldine R. Vink, Cornelis J. A. Punt, Anne M. May, Miriam Koopman, Jeroen W. G. Derksen
Neoadjuvant Short- Vs. Long-Course Radiation for Locally Advanced Rectal Cancer: How to Choose
Christopher G. Willett, Scarlett Acklin-Wehnert
Treatment Options for Distal Rectal Cancer in the Era of Organ Preservation
Chen Wang, Xiaoliang Liu, Weiping Wang, Zheng Miao, Xiaoyan Li, Dingchao Liu, Ke Hu
Social Determinants of Health and the Link to Colorectal Cancer Outcomes
Michael K. Lorentsen, Hanna K. Sanoff
A Comprehensive Review of Cancer Drug–Induced Cardiotoxicity in Blood Cancer Patients: Current Perspectives and Therapeutic Strategies
Vincenzo Costanzo, Yashwant Kumar Ratre, Emanuela Andretta, Rakesh Acharya, L. V. K. S. Bhaskar, Henu Kumar Verma
Who Should Receive Immunotherapy for Advanced Gastroesophageal Cancer?
Suhaib Khateeb, Ludimila Cavalcante, Noor Alnairat, Meghana Singh, Ibrahim Halil Sahin, Azhar Saeed, Anwaar Saeed
Circulating Tumor DNA (ctDNA) and Its Role in Gynecologic Malignancies
Tali Pomerantz, Rebecca Brooks
Ovarian Suppression: Early Menopause and Late Effects
Chiara Molinelli, Flavia Jacobs, Guilherme Nader-Marta, Roberto Borea, Graziana Scavone, Silvia Ottonello, Piero Fregatti, Cynthia Villarreal-Garza, Jyoti Bajpai, Hee Jeong Kim, Silvia Puglisi, Evandro de Azambuja, Matteo Lambertini
Update on Dosing and Fractionation for Neoadjuvant Radiotherapy for Localized Soft Tissue Sarcoma
Siyer Roohani, Lisette M. Wiltink, David Kaul, Mateusz Jacek Spałek, Rick L. Haas
Pioneering the Way: The Revolutionary Potential of Antibody–Drug Conjugates in NSCLC
Xiehui Chen, Changchun Zeng